Table Of Contents
1 Introduction 18
1.1 Objectives Of The Study 18
1.2 Market Definition 18
1.3 Overview Of North America Clinical Trial Supplies Market 19
1.4 Currency And Pricing 20
1.5 Limitation 20
1.6 Markets Covered 21
2 Market Segmentation 23
2.1 Markets Covered 23
2.2 Geographic Scope 24
2.3 Years Considered For The Study 25
2.4 Currency And Pricing 25
2.5 Research Methodology 26
2.6 Primary Interviews With Key Opinion Leaders 29
2.7 DBMR Market Challenge Matrix 30
2.8 Secondary Sources 31
2.9 Assumptions 31
3 Market Overview 32
3.1 Drivers 34
3.1.1 Rising Demand Of Clinical Trials Worldwide 34
3.1.2 Increasing Incidences Of Diseases 35
3.1.3 Government Funds To R&D Investments 36
3.1.4 Development Of New Treatments Such As Personalized Medicine 36
3.2 Restraints 37
3.2.1 Adverse Effects Of Clinical Trials 37
3.2.2 Transportation Issue 37
3.3 Opportunities 38
3.3.1 New Drug Development And Availability In Emerging Countrires 38
3.4 Challenges 39
3.4.1 Longer Procedure Time Of Clinical Trials Approval 39
4 Executive Summary 40
5 Premium Insights 42
6 North America Clinical Trial Supplies Market, By Services 44
6.1 Overview 45
6.2 Storage 47
6.3 Manufacturing 49
6.4 Packaging And Labeling 50
6.5 Distribution 52
7 North America Clinical Trial Supplies Market, By Clinical Phases 53
7.1 Overview 54
7.2 Phase Iii 56
7.3 Phase Ii 57
7.4 Phase Iv 58
7.5 Phase I 59
8 Mjknorth America Clinical Trial Supplies Market, By Therapeutic Use 61
8.1 Overview 62
8.2 Oncology 64
8.3 Cardiovascular Disease 66
8.4 Dermatology 67
8.5 Metabolic Disorders 68
8.6 Infectious Disease 69
8.7 Respiratory Diseases 70
8.8 Cns And Mental Disorders 71
8.9 Blood Disorders 72
8.10 Others 73
9 North America Clinical Trial Supplies Market, By End User 74
9.1 Overview 75
9.2 Contract Research Organizations 77
9.3 Pharmaceutical And Biotechnology Companies 78
10 North America Clinical Trial Supplies Market, By Geography 80
11 North America Clinical Trial Supplies Market, Company Landscape 81
11.1 Company Share Analysis; North America 81
12 Company Profile 82
12.1 Thermo Fisher Scientific Inc. 82
12.1.1 Company Overview 82
12.1.2 Revenue Analysis 82
12.1.3 Company Share Analysis 83
12.1.4 Product Portfolio 83
12.1.5 Recent Developments 84
12.2 Catalent, Inc.85
12.2.1 Company Overview 85
12.2.2 Revenue Analysis 85
12.2.3 Company Share Analysis 86
12.2.4 Product Portfolio 86
12.2.5 Recent Developments 87
12.3 Clinigen Group Plc. 88
12.3.1 Company Overview 88
12.3.2 Revenue Analysis 88
12.3.3 Revenue Analysis 89
12.3.4 Product Portfolio 89
12.3.5 Recent Developments 89
12.4 Parexel International Corporation 90
12.4.1 Company Overview 90
12.4.2 Revenue Analysis 90
12.4.3 Company Share Analysis 91
12.4.4 Product Portfolio 91
12.4.5 Recent Developments 91
12.5 Alium Medical Limited 92
12.5.1 Company Overview 92
12.5.2 Product Portfolio 92
12.5.3 Recent Developments 92
12.6 Almac Group 93
12.6.1 Company Overview 93
12.6.2 Geographic Presence 93
12.6.3 Product Portfolio 94
12.6.4 Recent Developments 94
12.7 Ancillare, Lp 95
12.7.1 Company Overview 95
12.7.2 Geographic Presence 95
12.7.3 Product Portfolio 96
12.7.4 Recent Developments 96
12.8 Biocair 97
12.8.1 Company Overview 97
12.8.2 Product Portfolio 97
12.8.3 Recent Developments 97
12.9 Bionical Ltd. 98
12.9.1 Company Overview 98
12.9.2 Gepographic Presence 98
12.9.3 Product Portfolio 99
12.9.4 Recent Developments 99
12.10 Clinical Supplies Management Holdings, Inc. 100
12.10.1 Company Overview 100
12.10.2 Geographic Presence 100
12.10.3 Product Portfolio 101
12.10.4 Recent Developments 101
12.11 Klifo 102
12.11.1 Company Overview 102
12.11.2 Geographic Presence 102
12.11.3 Product Portfolio 103
12.11.4 Recent Developments 103
12.12 Movianto 104
12.12.1 Company Overview 104
12.12.2 Geographic Presence 104
12.12.3 Product Portfolio 105
12.12.4 Recent Developments 105
12.13 Myoderm 106
12.13.1 Company Overview 106
12.13.2 Geographic Presence 106
12.13.3 Product Portfolio 107
12.13.4 Recent Developments 107
12.14 Pci Pharma Services 108
12.14.1 Company Overview 108
12.14.2 Geographic Presence 108
12.14.3 Product Portfolio 109
12.14.4 Recent Developments 109
12.15 Sharp 110
12.15.1 Company Overview 110
12.15.2 Geographic Presence 110
12.15.3 Product Portfolio 111
12.15.4 Recent Developments 112
12.16 Siro Clinpharm 113
12.16.1 Company Overview 113
12.16.2 Geographic Presence 113
12.16.3 Product Portfolio 114
12.16.4 Recent Developments 114
13 Related Reports 115